Biomedica Immunoassays

Biomedica Immunoassays is a specialized division of Biomedica Medizinprodukte GmbH, an Austrian life sciences company founded in 1978. The company is a leading developer and manufacturer of high-quality immunoassays, particularly ELISA kits, designed for clinical research and diagnostic applications. Their primary focus areas include bone metabolism, cardiovascular disease, nephrology, and oncology, where they provide validated tools for quantifying critical biomarkers like Sclerostin, FGF23, and NT-proBNP. Biomedica is recognized for its rigorous quality standards, maintaining ISO 9001 and ISO 13485 certifications to ensure the reliability and reproducibility of its products. In addition to its own R&D and manufacturing, the broader Biomedica Group acts as a major distributor for international biotechnology brands across Central and Eastern Europe. The company's products are used globally by researchers in academia and the pharmaceutical industry to advance the understanding of complex diseases.